Medivation common stock approved for listing on Amex

By Lisa Kerner

Erie, Pa., March 8 - Medivation, Inc. said its common stock has been approved for listing on the American Stock Exchange and is expected to begin trading under the symbol MDV at market open on March 15.

"The approval of our shares for listing on the Amex is an important milestone in the growth of our company," president and chief executive officer David Hung said in a company news release.

"Based on recent discussions with investors, we believe that an exchange listing may provide Medivation a number of benefits, including increased visibility in the financial community, greater liquidity for our stock and a larger potential investor base that includes those who cannot invest in unlisted securities."

San Francisco-based Medivation acquires, develops and markets pharmaceutical and medical device technologies in the late preclinical development phase.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.